CGC
CGC
NASDAQ · Pharmaceuticals

Canopy Growth Corp

$0.97
+0.01 (+1.50%)
As of Mar 25, 10:04 PM ET ·
Analyst Consensus
Strong Sell
13
Analysts
Moderate
Coverage
Buy 1 8%
Hold 5 38%
Sell 7 54%
Price Target
Analyst Price Target +2,315.0% upside
Low Target $17.63
Average Target $23.50
High Target $33.45
Current Price $0.97
Current
$0.97
Target
$23.50
$17.63 $23.50 avg $33.45
Scenario Analysis
Bear Case
$17.63
1,711.7%
Low target
Base Case
$23.50
+2,315.0%
Avg target
Bull Case
$33.45
+3,337.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.28
-70.3% from high
52-Week Low
$1.09
+-10.3% from low
Target vs 52W High
$23.50
+616.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%